John Connolly | BiotechTV

top of page

Search

SITC 2024: Parker Institute for Cancer Immunotherapy CSO John Connolly gives an overview of the latest advances in IO

Nov 9

SITC 2024: Parker Institute for Cancer Immunotherapy CSO John Connolly gives an overview of the latest advances in IO

He discusses the latest in TILs, cell therapy, multispecifics, oncolytic viruses and more.

Parker Institute for Cancer Immunotherapy's John Connolly on what he is seeing at #SITC23

Nov 4, 2023

Parker Institute for Cancer Immunotherapy's John Connolly on what he is seeing at #SITC23

John Connolly describes trends he is seeing in cell therapy, bi-specific engagers, myeloid checkpoint targets, and combinations.

The latest on immunotherapy with John Connolly.

Jan 11, 2023

The latest on immunotherapy with John Connolly.

Parker Institute's John Connolly provides an update on the latest in cancer immunotherapy at #JPM23.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh

bottom of page